Insider · CIK 0001202770

CARUSO JAMES V

Reports to the SEC for 3 companies · FLORHAM PARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001202770

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-07	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+250K sh	—	—	250,000
2026-05-07	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+8,680 sh	$2.88	+$25K	20,318
2026-05-07	CLRBCellectar Biosciences, Inc. · WarrantsP Purchase	Director, President & CEO	PPurchase	+26K sh	$0.01	+$260.4	36,076
2025-07-02	CLRBCellectar Biosciences, Inc. · WarrantsP Purchase	Director, President & CEO	PPurchase	+10K sh	$0.01	+$100	10,000
2025-07-02	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+10K sh	$4.99	+$49.9K	11,638
2025-02-14	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+900K sh	—	—	900,000
2024-06-14	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+900K sh	—	—	900,000
2023-12-08	CLRBCellectar Biosciences, Inc.A Award	Director, President & CEO	AAward	+40.6K sh	—	—	49,236
2023-06-23	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+261K sh	—	—	261,000
2023-01-17	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+261K sh	—	—	261,000
2022-01-25	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+1.42M sh	—	—	1,419,000
2021-03-04	CLRBCellectar Biosciences, Inc. · Series A WarrantsS Sale	Director, President & CEO	SSale	+46.9K sh	$0.19	+$8,718.244	0
2021-03-04	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+1.6M sh	—	—	1,600,000
2021-03-04	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+5,100 sh	$1.70	+$8,658.78	86,401
2020-12-28	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+37K sh	$1.35	+$50K	81,301
2020-06-05	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+21.7K sh	$1.15	+$24.9K	44,264
2020-06-05	CLRBCellectar Biosciences, Inc. · Series H WarrantsP Purchase	Director, President & CEO	PPurchase	+10.9K sh	$0.01	+$108.7	10,870
2020-02-03	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2020-02-03	CLRBCellectar Biosciences, Inc.A Award	Director, President & CEO	AAward	+100K sh	$2.71	+$271K	100,000
2019-01-17	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+75K sh	—	—	75,000
2018-11-30	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+1,000 sh	$2.28	+$2,282	22,354
2018-10-12	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+150K sh	—	—	150,000
2018-03-12	CLRBCellectar Biosciences, Inc.S Sale	Director, President & CEO	SSale	−34K sh	$1.20	−$40.7K	213,548
2017-04-18	CLRBCellectar Biosciences, Inc.A Award	Director, President & CEO	AAward	+200K sh	—	—	247,548
2016-05-12	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+200K sh	$0.01	+$2,000	237,500
2016-04-20	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+46.9K sh	$2.12	+$99.5K	47,548
2016-04-20	CLRBCellectar Biosciences, Inc. · Series A WarrantsP Purchase	Director, President & CEO	PPurchase	+46.9K sh	$0.01	+$469.48	46,948
2015-11-24	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+1,000 sh	$1.30	+$1,302	6,000
2015-11-20	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+1,000 sh	$1.16	+$1,159.3	5,000
2015-11-19	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+2,000 sh	$1.50	+$3,000	4,000
2015-11-18	CLRBCellectar Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+2,000 sh	$1.39	+$2,789.8	2,000
2010-03-01	ALLOS THERAPEUTICS INCStock Options (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−40K sh	—	—	60,000
2010-03-01	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−40K sh	$8.13	−$325K	141,159
2010-03-01	ALLOS THERAPEUTICS INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+40K sh	$3.13	+$125K	181,159
2010-03-01	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−37.5K sh	$8.13	−$305K	103,659
2010-02-23	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−5,968 sh	$7.44	−$44.4K	141,159
2010-02-22	ALLOS THERAPEUTICS INCStock Options (Right to Buy)A Award	Chief Commercial Officer	AAward	+102K sh	$7.56	+$773K	102,300
2010-02-22	ALLOS THERAPEUTICS INCA Award	Chief Commercial Officer	AAward	+58.3K sh	—	—	147,127
2009-08-10	ALLOS THERAPEUTICS INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+85.4K sh	$3.13	+$267K	174,273
2009-08-10	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−85.4K sh	$8.13	−$694K	88,873
2009-08-10	ALLOS THERAPEUTICS INCStock Options (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−85.4K sh	—	—	100,000
2009-08-05	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−14.6K sh	$8.13	−$119K	88,873
2009-08-05	ALLOS THERAPEUTICS INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+14.6K sh	$3.13	+$45.7K	103,473
2009-08-05	ALLOS THERAPEUTICS INCStock Options (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−14.6K sh	—	—	185,400
2009-08-03	ALLOS THERAPEUTICS INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+50K sh	$3.13	+$157K	138,873
2009-08-03	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−50K sh	$7.79	−$389K	88,873
2009-08-03	ALLOS THERAPEUTICS INCStock Options (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−50K sh	—	—	200,000
2009-06-16	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−13.5K sh	$8.16	−$110K	88,873
2009-06-15	ALLOS THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−14K sh	$8.13	−$114K	102,373
2009-03-26	ALLOS THERAPEUTICS INCStock Options (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−39.5K sh	—	—	250,000

Recent filings

Accepted (ET)
Jul 84
CARUSO JAMES V0001104659-26-082014
SEC(opens sec.gov)
May 114
CARUSO JAMES V0001104659-26-058851
SEC(opens sec.gov)
Jul 34
CARUSO JAMES V0001104659-25-065573
SEC(opens sec.gov)
Feb 184
CARUSO JAMES V0001104659-25-014730
SEC(opens sec.gov)
Jun 184
CARUSO JAMES V0001104659-24-072889
SEC(opens sec.gov)
Dec 124
CARUSO JAMES V0001104659-23-125483
SEC(opens sec.gov)
Jan 184
CARUSO JAMES V0001104659-23-004700
SEC(opens sec.gov)
Jan 274
CARUSO JAMES V0001104659-22-008277
SEC(opens sec.gov)
Mar 54
CARUSO JAMES V0001104659-21-032850
SEC(opens sec.gov)
Dec 284
CARUSO JAMES V0001104659-20-139787
SEC(opens sec.gov)
Jun 84
CARUSO JAMES V0001104659-20-070837
SEC(opens sec.gov)
Mar 54/A
CARUSO JAMES V0001104659-20-029693
SEC(opens sec.gov)
Feb 44
CARUSO JAMES V0001104659-20-010608
SEC(opens sec.gov)
Jan 184
CARUSO JAMES V0001144204-19-002085
SEC(opens sec.gov)

Companies

Address

C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE

FLORHAM PARK, NJ, 07932